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Sequencing of 16S rRNA Gene: 
A Rapid Tool for Identification 
of Bacillus anthracis 
Claudio T. Sacchi,*† Anne M. Whitney,* Leonard W. Mayer,* Roger Morey,* 
Arnold Steigerwalt,* Arijana Boras,*‡ Robin S. Weyant,* and Tanja Popovic*
In a bioterrorism event, a tool is needed to rapidly differentiate Bacillus anthracis from other closely related
spore-forming  Bacillus species. During the recent outbreak of bioterrorism-associated anthrax, we
sequenced the 16S rRNA genes from these species to evaluate the potential of 16S rRNA gene
sequencing as a diagnostic tool. We found eight distinct 16S types among all 107 16S rRNA gene
sequences that differed from each other at 1 to 8 positions (0.06% to 0.5%). All 86 B. anthracis had an
identical 16S gene sequence, designated type 6; 16S type 10 was seen in all B. thuringiensis strains; six
other 16S types were found among the 10 B. cereus strains. This report describes the first demonstration
of an exclusive association of a distinct 16S sequence with B. anthracis. Consequently, we were able to
rapidly identify suspected isolates and to detect the B. anthracis 16S rRNA gene directly from culture-neg-
ative clinical specimens from seven patients with laboratory-confirmed anthrax.
he gram-positive, rod-shaped, and spore-forming bacte-
rium Bacillus anthracis is the cause of the acute and often
lethal disease anthrax. Phenotypic characteristics commonly
used to differentiate B. anthracis from closely related B.
cereus and B. thuringiensis, such as susceptibility to ß-lactam
antibiotics, lack of motility, lack of hemolysis on sheep blood
agar (SBA) plate, and susceptibility to γ -phage lysis, may vary
among different Bacillus species strains, hampering their iden-
tification and differentiation. Phenotypically and genotypically
B. thuringiensis can be differentiated from B. cereus by the
presence of the CRY crystal protein and plasmid-encoded cry
genes (1), but if this plasmid were lost, B. thuringiensis could
no longer be distinguished from B. cereus (1). The sequence of
the 16S rRNA gene has been widely used as a molecular clock
to estimate relationships among bacteria (phylogeny), but
more recently it has also become important as a means to iden-
tify an unknown bacterium to the genus or species level. The
16S rRNA gene sequences of B. anthracis, B. cereus, and B.
thuringiensis have high levels of sequence similarity (>99%)
that support their close relationships shown by DNA hybrid-
ization (2–7). A limited number of 16S rRNA sequences of B.
anthracis (7 sequences), B. cereus (34 sequences), and B. thur-
ingiensis  (16 sequences) have been available at GenBank.
Although those sequences are of different lengths and quali-
ties, in complementary regions they differ from each other by
no more than a few nucleotides. Therefore, this minimal level
of diversity seen in the 16S rRNA of B. anthracis, B. cereus,
and B. thuringiensis was thought to be an obstacle for using
16S rRNA gene sequencing to identify and differentiate these
three species. The bioterrorism events of October 2001
prompted us to evaluate several new molecular approaches to
rapidly identify B. anthracis. We determined the entire 16S
rRNA sequences in a large number of representative strains of
B. anthracis, B. cereus, and B. thuringiensis to evaluate the
potential of 16S rRNA sequencing not only to rapidly identify
B. anthracis in culture, but also to detect B. anthracis directly
in clinical specimens.
Materials and Methods
Bacterial Strains
A total of 107 strains were included in this study. Of 86 B.
anthracis isolates analyzed (Table 1), 18 were selected to rep-
resent a wide range of temporal (1937–1997), geographic (16
countries), and source diversity (soil, animals, or humans).
Fourteen reference and standard strains, such as the Vollum,
Ames, Pasteur, New Hampshire, V770, and Sterne strains,
were also included. The remaining 54 strains were isolated
from October to December 2001 during the bioterrorism-asso-
ciated anthrax outbreak in the United States. Ten B. cereus and
11 B. thuringiensis strains were also analyzed by 16S rRNA
sequencing. All strains were identified by standard microbio-
logic procedures and according to the Laboratory Response
Network diagnostic criteria (9,10).
Clinical Specimens
We analyzed 198 clinical specimens (76 blood, 30 tissue,
16 pleural fluid, 37 serum, 6 cerebrospinal fluid, and 33 other
specimens). Sixty-nine specimens were obtained from patients
with laboratory-confirmed anthrax (55 specimens from 11
inhalational cases and 14 from 7 cutaneous cases). DNA was
extracted from fluid (200 µL) or small tissue specimens (<5
mm3) according to manufacturer's instructions with a Qiagen
DNA Mini Kit (Qiagen, Valencia, CA). All 198 DNA samples
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Table 1.  Descriptions and GenBank accession numbers of 107 Bacillus species strains analyzed in this study
Species No. Identification
GenBank 16S rRna gene 
accession number
Geographic and/or  
temporal origina
16S rRNA 
type
MLVA 
genotypeb
B. anthracis Diversity collection 18 2000031650 AY138379 Human, Turkey, 1991 6 23
2000031651 AY138372 Bovine, France, 1997 6 80
2000031652 AY138374 Human, US, 1952 6 68
2000031653 AY138373 Wool, Pakistan, 1976 6 69
2000031655 AY138376 Cow, China 6 57
2000031656 AY138375 Ames 6 62
2000031657 AY138382 Bovine 6 10
2000031659 AY138377 Human, Turkey, 1984 6 28
2000031660 AY138378 Bovine, US, 1937 6 25
2000031661 AY138369 Human, South Korea, 1994 6 34
2000031662 AY139368 Zebra, Namibia 6 35
2000031663 AY138381 Bovine, Poland 6 15
2000031664 AY138383 Porcine, German, 1971 6 38
2000031665 AY138366 Bovine, Argentina 6 45
2000031666 AY138371 UK 6 77
2000031667 AY138380 Sheep, Italy, 1994 6 20
2000031670 AY138367 Human, Turkey, 1985 6 41
2000031671 AY138370 Bovine, Zambia 6 30
Standard and reference strains 14 Ames AY138358 Ames 6 62
2002007651 AY138355 Sterne, Chile 6 ND
2002007650 AY138356 Sterne, Chile 6 ND
2002007649 AY138357 Pasteur, Chile 6 ND
2000031887B AY138347 Vaccine 6 ND
2000031666 AY138352 Vollum 6 77
2000031368 AY138350 Vollum 6 77
2000031244 AY138354 Vollum 6 *
2000031078 AY138351 Vollum M36 6 ND
2000031076 AY138353 Vollum 6 *
2000031259 AY138346 Pasteur 6 **
2000031075 AY138345 Sterne 6 *
2000031887 AY138348 V770-NP1-R 6 *
2000031136 AY138349 New Hampshire 6 73
Outbreak strains 54 AY138291 to AY138344 US Oct/Dec 2001 6 62
B. cereus 10 2000031486 AY138272 Human, US, 1994 12 NA
2000031491 AY138276 Human, US, 1997 7 NA
2000031498 AY138274 Human, US, 1979 9 NA
2000031503 AY138277 Human, US, 1999 7 NA
2000031513 AY138279 Human, US, 1986 13 NA
G3317 AY138278 Human, Israel, 1989 7 NA
G8639 AY138271 Milk, Bolivia, 1993 3 NA
G9667 AY138273 Human, US, 1995 12 NA
H1439 AY138270 Human, US, 2000 2 NA
ATCC 14579 AY138275 1887 9 NA
B. thuringiensis 11 2000031482 AY138290 Human, US, 1989 10 NA
2000031485 AY138289 Spray, US, 1993 10 NA
2000031494 AY138288 Human, US, 1985 10 NA
2000031496 AY138287 Human, US, 1981 10 NAEmerging Infectious Diseases  •  Vol. 8, No. 10, October 2002 1119
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were analyzed for 16S rRNA gene amplification and products
sequenced.
Polymerase Chain Reaction (PCR)
A 1,686-bp fragment of DNA, including the 1,554-bp 16S
rRNA gene, was amplified from all 107 Bacillus species
strains by using primers 67F and 1671R (Table 2). For clinical
samples, we used the initial DNA amplicon as a template in a
nested PCR with a second set of internal primers, 23F and
136R (Table 1). Both sets of primers were designed from the
B. anthracis genome sequence (http://www.tigr.org). The full-
length size of B. anthracis 16S rRNA gene (1,554 bp) was
determined from an alignment of the 16S rRNA genes from
Escherichia coli, Neisseria gonorrhoeae (GenBank accession
nos. J01859 and X07714, respectively), and the 16S rRNA
gene regions of the B. anthracis genome sequence (http://
www.tigr.org). Whole cell suspensions or DNA extracts were
used for PCR of isolates or clinical samples, respectively. For
whole cell suspensions, a single colony from an SBA plate
was resuspended in 200 µL of 10 mM Tris, pH 8.0. The sus-
pension was put in a Millipore 0.22-µm filter unit (Millipore,
Bedford, MA), heated at 95°C for 20 min, centrifuged at 8,000
rpm for 2 min, and then used for PCR. Each final PCR reaction
(100 µL) contained 5 U of Expand DNA polymerase (Roche,
Mannheim, Germany); 2 µL of whole cell suspension or DNA;
10 mM Tris-HCl (pH 8.0); 50 mM KCl; 1.5 mM MgCl2; 200
µM (each) dATP, dCTP, dGTP, and dTTP; and 0.4 µM of each
primer. Reactions were first incubated for 5 min at 95ºC. Then
35 cycles were performed as follows: 15 s at 94ºC, 15 s at the
annealing temperature of 52ºC, and 1 min 30 s at 72ºC. Reac-
tions were then incubated at 72ºC for another 5 min. The
annealing temperature for the nested PCR was 50ºC. PCR
products were purified with Qiaquick PCR purification kit
(Qiagen).
16S rRNA Sequence Determination
The amplified products of approximately 1,686 bp (1,656
bp for nested PCR) were sequenced by using a modification of
16 primers as described (Table 2) (11). Sequencing was per-
formed by using a Big Dye terminator cycle sequencing kit
(Applied BioSystems, Foster City, CA). Sequencing products
were purified by using Centri-Sep spin columns (Princeton
Separations, Adelphia, NJ) and were resolved on an Applied
BioSystems model 3100 automated DNA sequencing system
(Applied BioSystems). The length of sequences obtained dif-
fered for each primer but were sufficient to provide 5- to 8-
fold sequence coverage. An inner fragment of 1,554 bp was
Table 1 continued.  Descriptions and GenBank accession numbers of 107 Bacillus species strains analyzed in this study
Species No. Identification
GenBank 16s rRna gene 
accession number
Geographic or  temporal 
origina
16S rRNA 
type
MLVA 
genotype
2000031508 AY138286 Human, US, 1985 10 NA
2000031509 AY138285 Human, US, 1985 10 NA
2002007400 AY138283 Powder, US, 2001 10 NA
2002017401 AY138284 Powder, US, 2001 10 NA
2000032755 AY138282 Environment, US, 2000 10 NA
2000032757 AY138280 Environment, US, 2000 10 NA
2000032756 AY138281 Human, US, 1981 10 NA
a Date and source of isolation are provided when available;  *,  lacking pXO2; **,  lacking pXO1.
bND, MLVA (8).
NA, not applicable.
Table 2. Primers used for amplification and sequencing of the 16S 
rRNA gene of Bacillus anthracis, B. thuringiensis, and B. cereusa
Generic primers used for 16S rRNA amplification
8F 5´AGT TGA TCC TGG CTC AG 3´
1492R 5´ACC TTG TTA CGA CTT3´
Primers for amplification of the 16S rRNA gene
67F 5´TGA AAA CTG AAC GAA ACA AAC 3´
1671R 5´CTC TCA AAA CTG AAC AAA ACG AAA 3´
Inner primers used for nested PCR on clinical samples
23F 5´ACA AAC AAC GTG AAA CGT CAA 3´
136R 5´AAA CGA AAC ACG GAA ACT T 3´
Primers used for sequencing of the 16S rRNA gene
104F 5´GGA CGG GTG AGT AAC ACG TG 3´
104R 5´CAC GTG TTA CTC ACC CGT CC 3´
1230F 5´TAC ACA CGT GCT ACA ATG 3´
1390F 5´GGG CCT TGT ACA CAC CG 3´
1390R 5´CGG TGT GTA CAA GGC CC 3´
8F 5´AGT TGA TCC TGG CTC AG 3´
357F 5´TAC GGG AGG CAG CAG 3´
357R 5´CTG CTG CCT CCC GTA 3´
530F 5´CAG CAG CCG CGG TAA TAC 3´
530R 5´GTA TTA CCG CGG CTG CTG 3´
790F 5´ATT AGA TAC CCT GGT AG 3´
790R 5´CTA CCA GGG TAT CTA AT 3´
981F 5´CCC GCA ACG AGC GCA ACC C 3´
981R 5´GGG TTG CGC TCG TTG CGG G 3´
aPrimers 67F and 1671R or primers 23F and 136R were also used for 16S sequence on 
isolates or clinical samples, respectively.BIOTERRORISM-RELATED ANTHRAX
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obtained and analyzed by using the GCG (Wisconsin) Pack-
age, v. 10.1, (Genetics Computer Group, Madison, WI). A
number was assigned for each allele of 16S rRNA gene
sequence in order of elucidation; a single base change or a
mixed base (more than one nucleotide determined at a single
position) was considered a new 16S type. When a novel 16S
type, mixed base pairs, or any discrepancies in the alignment
were obtained, the 16S rRNA gene amplification and sequenc-
ing of the entire gene or parts containing the problematic
region were repeated. 
GenBank 16S rRNA Gene Sequences 
and Accession Numbers
Sixty 16S rRNA gene sequences of B. anthracis, B. cereus,
and B. thuringiensis were available in GenBank. Thirty-nine
of these sequences were incomplete, contained a large number
of undetermined nucleotides, or were not associated with a
specific strain identification, and therefore were not used in
this study. The remaining 21 sequences were identified as
eight  B. anthracis (AF155950 [Ames]), (AF155951 [Delta
Ames]), (AF176321 [Sterne]), (AF290552 [Sterne]),
(AF290553 [Vollum]), (AF155950 [Ames]), (AF155951
[Delta Ames]), and (AF176321 [Sterne]); eight B. cereus
(AF155952, AF155958, AF176322, AF290546, AF290547,
AF290548, AF290550, and AF290555); three B. thuringiensis
(AF155954, AF155955, and AF290549); and two B. mycoides
(AF155956 and AF155957). A total of 114 16S rRNA gene
sequences were determined in this study (107 from isolates
[GenBank accession nos. in Table 1] and 7 from clinical speci-
mens [GenBank accession nos. AY138359 to AY138365). 
Results
16S rRNA Gene Sequence Diversity
The 1,554-bp nucleotide sequences of the entire 16S rRNA
gene from all 107 Bacillus species strains were aligned and
compared. Differences were found at eight single nucleotide
positions (positions 1, 2, 3, 4, 6, 9, 12, and 13), and no gaps
were present. When 21 Bacillus 16S rRNA sequences from
GenBank were added to the alignment, five additional posi-
tions with differences (positions 5, 7, 8, 10, and 11) were
located (Table 3). The 13 positions of differences were distrib-
uted throughout the gene (Table 3). In six of these positions
(positions 1, 2, 3, 4, 6, and 12), more than one nucleotide was
detected (mixed nucleotides) (Table 3). These results indicated
that the strain contained multiple rRNA operons with slightly
different 16S rRNA gene sequences. 
We found eight different 16S types among the 107 16S
rRNA genes from our collection of isolates (Table 3). All 86 B.
anthracis had an identical sequence, 16S type 6, containing a
single mixed base, a W(A/T) at position 12, not found in the
other two species. 16S type 10 was seen in all 11 B. thuring-
iensis strains, and a single mixed base pair was identified in all
strains at position 6. Six other 16S types were found among
the 10 B. cereus strains. Three additional 16S types were found
among the 18 GenBank sequences that we analyzed. 16S types
1, 4, and 5 correlated to B. mycoides, B. thuringiensis, and B.
cereus, respectively (Table 3). Five B. anthracis sequences
from GenBank were identical to the 16S type 6 found in all our
86 B. anthracis isolates, and three were identical to the 16S
type 7 found in B. cereus.
16S rRNA Sequencing Directly in Clinical Specimens
We detected 16S rRNA genes in 7 (3.5%) of 198  clinical
samples: all were 16S type 6 characteristic for B. anthracis.
None of the seven specimens were culture positive (Table 4),
although all specimens had been collected from patients with
laboratory-confirmed anthrax.
Discussion
The goal of this study was to evaluate the potential of 16S
rRNA sequencing to rapidly identify B. anthracis in cultures.
We found that 16S rRNA genes of B. anthracis were highly
conserved; only one 16S type (16S type 6) was identified in all
86 strains tested. However, not all B. anthracis 16S rRNA
genes sequences in GenBank are type 6. Three of the eight B.
anthracis 16S rRNA sequences are reported as type 7, a type
that, in our study, we found exclusively among the B. cereus
strains. The only difference between type 7 and type 6 is a
mixed base pair at position 1146. The strain designations of
two of these three 16S type 7 B. anthracis strains in GenBank
are Ames and Sterne. We did not acquire these particular
strains from the submitting laboratory, but the one Ames and
two Sterne strains (obtained from different sources) in our col-
lection were consistently type 6. A third Sterne strain 16S
rRNA sequence in GenBank is also type 6. 
One possible explanation for these different 16S rRNA
sequencing results may be the use of different sequencing
approaches, such as using cloned DNA versus genomic DNA
as template. In sequencing clones, one allele may be missed if
only a few clones are sequenced, not representing the total
diversity. In this case, the position with the mixed base would
not be detected. If both types 6 and 7 exist in B. anthracis, the
difference may be due to recombination, mutation, or loss of
an allele. The type 7 B. anthracis sequences in GenBank are
unpublished; therefore, we do not know if the genes were
cloned and, if so, how many clones were sequenced. 
The complete B. anthracis genome was posted at http://
www.tigr.org/tigr-scripts/ufmg/ReleaseDate.pl on May 7,
2002. The genome has 11 rRNA operons. There are 10 posi-
tions in the 16S rRNA gene where the nucleotides are not
identical among the 11 rRNA operons, but the DNA sequenc-
ing software scores only one of them as a mixed base 100% of
the time. This position is 1146, where five 16S rRNA genes
contain Ts and six have As in a 54%:46% ratio. In this case,
the base-calling software (GCG; Genetics Computer Group)
always assigns a W at that position. At position 1137, there are
seven Gs and four As, a 64%:36% ratio, but the position is
scored as a G, the predominant base. In eight positions, a
9%:91% ratio is present. For example, at position 1047 are oneEmerging Infectious Diseases  •  Vol. 8, No. 10, October 2002 1121
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T and 10 Cs. In these cases, the nucleotide is called as the pre-
dominant base by the base-calling software. 
The quality of DNA sequences generated in laboratories
has been greatly improved by the introduction of automated
sequencing systems and DNA alignment software, but other
factors, such as the purity of the DNA template and number of
overlapping nucleotide fragments in the alignment, contribute
to the reliability of the final sequence. Mixed base pairs are
clearly the result of sequence differences between different
rRNA operons and not due to any sequencing artifacts. In this
study, the length of the fragment sequences varied for each
primer, but they were of sufficient length to provide 5- to 8-
fold sequence coverage in both directions. This 5–8 sequence
overlap simplifies identifying and clarifying positions with
double signals, increasing the confidence in our final consen-
sus sequence. The occurrence of mixed base pairs in rRNA
sequences is well known and accepted (15–19). The Riboso-
mal Database Project Web site shows that operon heterogene-
ity has been documented in several different bacterial species
(http://rrndb.cme.msu.edu/rrndb/rrn_table.pdf). In addition,
we did not observe mixed base pairs in single-copy genes such
as pagA and a variety of others. A previous study of a small set
of Bacillus strains isolated from soil demonstrated the diver-
sity of 16S rRNA genes of both B. cereus and B. thuringiensis
(15). Our results confirm the diversity among B. cereus strains,
although we did not find diversity among B. thuringiensis
strains. The lack of diversity in our collection of B. thuringien-
sis strains may be associated with natural selection with
human host; 6 of 11 of our B. thuringiensis strains were iso-
lated from humans. 
Direct Amplification of 16S rRNA from Clinical Samples
Even though B. anthracis is present at high levels (up to
108/mL) in the blood of patients with anthrax and will readily
grow on standard bacteriologic media, as for other bacteria,
specimens collected after the administration of antimicrobial
therapy may fail to grow B. anthracis. Laboratory confirma-
tion for the two patients with inhalational anthrax whose spec-
imens were analyzed (patient #10i [12], and patient #11i [13])
was achieved by isolation and identification of B. anthracis
from clinical samples at the medical facility where the patients
were treated. Generally, for all patients, isolates themselves
were forwarded to the appropriate public health laboratory and
then to the Centers for Disease Control and Prevention for
confirmatory identification and molecular subtyping, but the
initial clinical specimens were not sent along with the isolates.
With few exceptions, clinical specimens available for analysis
from these two patients and from other patients with inhala-
tional anthrax were collected after initiation of antimicrobial
therapy, resulting in few culture-positive results. For 3 of the
11 inhalational patients, laboratory confirmation was based on
two of three available supportive tests, including PCR target-
ing two plasmid and one chromosomal target (14), immuno-
histochemistry or a reactive anti-protective antigen titer
(immunoglobulin G ELISA) (12,20). Laboratory confirmation
for the two cutaneous cases with skin biopsies analyzed in this
Table 3. 16S rRNA gene types identified among 125 Bacillus spp. strains analyzed in this study (n=107) and available at GenBank (n=18)
 16S type
Bacillus 
species
No. of 
strains
Positionsa
1 2 34 5 6 78 9 1 01 1 1 2 1 3
(77) (90) (92) (182) (189) (192) (200) (208) (1,015) (1,036) (1,045) (1,146) (1,462)
16S types identified in 107 strains in this study
2 cereus 1R b YWC c A T T G A T AAA
3 cereus 1 G C A Y A T T G A T AAA
6 anthracis 86 A T T C A C T G C T A W T
7 cereus 3A T TCA C TGC T A A T
9 cereus 2A T TCA C TGA T A A T
10 thuringiensis 11 A T T C A Y T G A T A A T
12 cereus 2A T TYA T TGA T A A T
13 cereus 1A T TCA C TGC T A T T
16S types identified in strains available at GenBankd
1 mycoides 2A T T CC CG CC C G A - e
4 thuringiensis 3G C ACA T TGA T A A -
5 cereus 8G C ACA C TGA T A A -
7 anthracis 3A T TCA C TGC T A A T
aNumbers refer to the number of positions where mismatches are found. Numbers in parentheses refer to positions in the 16S rRNA gene.
bR refers to a purine (A or G) at that position; Y refers to a pyrimidine (C or T) at that position; and W refers to an A or T at that position.
cA, C, G, and T refer to the four deoxynucleotides that DNA comprises.
dFive additional positions of differences (positions 5, 7, 8, 10, and 11) were found when GenBank sequences were used.
eThe last position (position 13) on 16S types 1, 4, and 5 is missing because those GenBank sequences are shorter.BIOTERRORISM-RELATED ANTHRAX
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study was indeed achieved by these supportive laboratory
tests: one case was confirmed by immunohistochemistry and a
reactive anti-protective antigen title (IgG ELISA). For the
other case all three supportive laboratory tests were positive. 
Previously, strains having <3% difference between their
16S rRNA genes were considered the same species (21). How-
ever, differences between 16S rRNA genes for some Bacillus
species, such as B. anthracis, B. cereus, and B. thuringiensis,
are <1% (1). Such small differences (e.g., one base between
sequences or partial matches at a single nucleotide position in
the 16S rRNA gene) have not been used for species differenti-
ation. Our study clearly demonstrates that such small differ-
ences might be important for species identification. DNA-
DNA hybridization and 16S rRNA sequencing studies have
shown that these three Bacillus species are closely related and
probably represent a single species (3,6,7). If the three were
classified as a single species, 16S rRNA sequencing appears to
have the potential to differentiate strains at the subspecies
level.
Although pXO1 and pXO2 plasmids must be detected to
confirm the virulence of B. anthracis, 16S rRNA sequencing
has a powerful capacity to rapidly identify B. anthracis and
other species. Although further studies are needed to fully
evaluate 16S sequencing as a diagnostic assay, its value as a
tool for rapid initial screening in outbreak investigations has
been demonstrated. 
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7c Cutaneous anthrax IHC + PCR on skin biopsy Skin from forehead Neg Pos
aPatient identification numbers are described in references 12 and 13; I, inhalational case; C, cutaneous case; PCR, polymerase chain reaction.
bThe immunohistochemical (IHC), serologic, and PCR results are described in reference 14.Emerging Infectious Diseases  •  Vol. 8, No. 10, October 2002 1123
BIOTERRORISM-RELATED ANTHRAX
16. Nubel U, Engelen B, Felske A, Snaidr J, Wieshuber A, Amann RI, et al.
Sequence heterogeneities of genes encoding 16S rRNAs in Paenibacillus
polymyxa detected by temperature gradient gel electrophoresis. J Bacte-
riol 1996;178:5636–43.
17. Rainey FA, Ward-Rainey NL, Janssen PH, Hippe H, Stackebrandt E.
Clostridium paradoxum DSM 7308T contains multiple 16S rRNA genes
with heterogeneous intervening sequences. Microbiology
1996;142:2087–95.
18. Liefting LW, Andersen MT, Beever RE, Gardner RC, Forster RL.
Sequence heterogeneity in the two 16S rRNA genes of Phormium yellow
leaf phytoplasma. Appl Environ Microbiol 1996;62:3133–9.
19. Mylvaganam S, Dennis PP. Sequence heterogeneity between the two
genes encoding 16S rRNA from the halophilic archaebacterium Haloar-
cula marismortui. Genetics 1992;130:399–410.
20. Centers for Disease Control and Prevention. Update: investigation of
anthrax associated with intentional exposure and interim public health
guidelines, October 2001. MMWR Morb Mortal Wkly Rep 2001;50:889–
93.
21. Stackebrandt E, Goebel BM. Taxonomic note: a place for DNA-DNA
reassociation and 16S rRNA sequence analysis in the present species in
bacteriology. Int J Syst Bacteriol 1994;44:846–9.
Address for correspondence: Claudio T. Sacchi, Meningitis and Special Patho-
gens Branch, Centers for Disease Control and Prevention, 1600 Clifton Rd.,
N.E., Mailstop D11, Atlanta, GA 30333, USA; fax: 404-639-4421; e-mail:
cls9@cdc.gov 
Types of Articles 
Perspectives. Articles should be under 3,500 words and should include refer-
ences, not to exceed 40. Use of subheadings in the main body of the text is rec-
ommended. Photographs and illustrations are encouraged. Provide a short
abstract (150 words) and a brief biographical sketch of first author. Articles in
this section should provide insightful analysis and commentary about new and
reemerging infectious diseases and related issues. Perspectives may also
address factors known to influence the emergence of diseases, including
microbial adaptation and change, human demographics and behavior, technol-
ogy and industry, economic development and land use, international travel and
commerce, and the breakdown of public health measures. If detailed methods
are included, a separate section on experimental procedures should immedi-
ately follow the body of the text. 
Synopses. Articles should be under 3,500 words and should include refer-
ences, not to exceed 40. Use of subheadings in the main body of the text is rec-
ommended. Photographs and illustrations are encouraged. Provide a short
abstract (150 words) and a brief biographical sketch of first author—both
authors if only two. This section comprises concise reviews of infectious dis-
eases or closely related topics. Preference is given to reviews of new and
emerging diseases; however, timely updates of other diseases or topics are also
welcome. If detailed methods are included, a separate section on experimental
procedures should immediately follow the body of the text. 
Research Studies. Articles should be under  3,500 words and should include
references, not to exceed 40. Use of subheadings in the main body of the text is
recommended. Photographs and illustrations are encouraged. Provide a short
abstract (150 words) and a brief biographical sketch of first author—both
authors if only two. Report laboratory and epidemiologic results within a pub-
lic health perspective. Although these reports may be written in the style of tra-
ditional research articles, they should explain the value of the research in
public health terms and place the findings in a larger perspective (i.e., "Here is
what we found, and here is what the findings mean").
Policy and Historical Reviews. Articles should be under 3,500 words and
should include references, not to exceed 40. Use of subheadings in the main
body of the text is recommended. Photographs and illustrations are encour-
aged. Provide a short abstract (150 words) and a brief biographical sketch.
Articles in this section include public health policy or historical reports that are
based on research and analysis of emerging disease issues.
Dispatches. Articles should be 1,000–1,500 words and need not be divided
into sections. If subheadings are used, they should be general, e.g., “The
Study” and “Conclusions.” Provide a brief abstract (50 words); references (not
to exceed 15); figures or illustrations (not to exceed two); and a brief biograph-
ical sketch of first author—both authors if only two. Dispatches are updates on
infectious disease trends and research. The articles include descriptions of new
methods for detecting, characterizing, or subtyping new or reemerging patho-
gens. Developments in antimicrobial drugs, vaccines, or infectious disease pre-
vention or elimination programs are appropriate. Case reports are also
welcome. 
Commentary. Thoughtful discussions (500–1,000 words) of current topics.
Commentaries may contain references but should not include figures or tables.
Another Dimension. Thoughtful essays, short stories, or poems on philosoph-
ical issues related to science, medical practice, and human health. Topics may
include science and the human condition, the unanticipated side of epidemic
investigations, or how people perceive and cope with infection and illness. This
section is intended to evoke compassion for human suffering and to expand the
science reader's literary scope. Manuscripts are selected for publication as
much for their content (the experiences they describe) as for their literary
merit.
Letters. This section includes letters that present preliminary data or comment
on published articles. Letters (500–1,000 words) should not be divided into
sections, nor should they contain figures or tables. References (not more than
10) may be included.
Book Reviews. Short reviews (250–500 words) of recently published books on
emerging disease issues are welcome. The name of the book, publisher, and
number of pages should be included.
News and Notes. We welcome brief announcements (50–150 words) of timely
events of interest to our readers. (Announcements may be posted on the journal
Web page only, depending on the event date.) In this sec-tion, we also include
summaries (500–1,000 words) of emerging infectious disease conferences.
Summaries may provide references to a full report of conference activities and
should focus on the meeting's content.
Instructions for Authors